2m 2m 2m 2m 2m 2m 2m
CARDIFF ONCOLOGY (CRDF)
NASDAQ
$1.21$0.00 (0.00%)
Price as of Sep 11, 2026 7:30 PM EDT- $94.1MMarket Cap
- -40.98%1-Year Change
- BiotechnologyIndustry
CARDIFF ONCOLOGY (CRDF)
$1.21$0.00 (0.00%)
CRDF | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $1.21 | ||
Change | $0.00 (0.00%) | ||
Open | $1.21 | ||
High | $1.22 | ||
Low | $1.17 | ||
Previous Close | $1.21 | ||
Volume | 493,354 | ||
30-Day Average Volume | 661,633 | ||
1-Week Change | 11.01% | ||
1-Month Change | 15.24% | ||
1-Year Change | -40.98% | ||
3-Year Change | -38.27% | ||
5-Year Change | -80.79% | ||
Fundamentals | |||
Shares Outstanding | 77.8M | ||
Total Assets | $37.3M | ||
Market Cap | $94.1M | ||
Enterprise Value | $84.9M | ||
Period: QTR TTM FY | |||
Revenue | $104,000.00 | ||
Net Income | -$9.2M | ||
Free Cash Flow | -$11.8M | ||
EBIT | -$9.2M | ||
EBITDA | -$9.1M | ||
Net Working Capital | $24.8M | ||
EPS | -$0.14 | ||
Enterprise Value/EBITDA | -9 | ||
Enterprise Value/Revenue | 817 | ||
P/B | 4 | ||
P/E | -9 | ||
PEG | -0 | ||
Price/Free Cash Flow | -8 | ||
Price/Operating Cash Flow | -8 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 6 | ||
Last Split Date | 02/20/2019 | ||
Earnings & Revenue